- Immunotherapeutics Global Market - Forecast To 2021
- Some of the key players of the immunotherapeutics market are AbbVie (U.S.), Amgen (U.
- For Prescription Drug Makers, Price Increases Drive Revenue
- But Biogen's U.S. revenue from the drug kept growing as it raised the price up to three times a year.
- BENEPALI®, the First Etanercept Biosimilar Referencing Enbrel®, Approved in
- ZUG, Switzerland--(BUSINESS WIRE)--The joint venture between Biogen (NASDAQ:BIIB) and Samsung BioLogics, Samsung Bioepis, has been granted European Commission (EC) approval for BENEPALI® , an etanercept biosimilar referencing Enbrel®i.
- Stunning bounce-back for US high-grade
- Biotech firm Gilead Sciences amassed a US$36bn book for the week's biggest deal - a US$10bn six-parter - while sector rival Biogen's US$6bn offering was more than three times subscribed. Deals overall were three to 3.5 times covered, and as the week ...
Biogenous is described in multiple online sources, as addition to our editors' articles, see section below for printable documents, Biogenous books and related discussion.
Suggested News Resources
Great care has been taken to prepare the information on this page. Elements of the content come from factual and lexical knowledge databases, realmagick.com library and third-party sources. We appreciate your suggestions and comments on further improvements of the site.